NASDAQ

Aktis Oncology, Inc. (AKTS)

♥ 580 Thanks from members

Live price chart, market sentiment, and community perspectives for Aktis Oncology, Inc. (NASDAQ: AKTS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Scientific FoundersLeadership: Abbey Jenkins (CEO)Leadership: Neil CampbellHolder: Venture Capital InvestorsHolder: Institutional HoldersTargeted RadiopharmaceuticalsOncology Therapeutics#AKTS stock#Aktis Oncology#NASDAQ AKTS#radiopharmaceuticals#biotech startup